Inventor · disambiguated record
Jianhua Yu
Also filed as: YU JIANHUA
20 granted patents·31 pending applications·36 citations·filing 2004–2025
91Inventor score
Files withHOPE CITY16OHIO STATE INNOVATION FOUNDATION10CYTOIMMUNE THERAPEUTICS INC8CHINA PETROLEUM & CHEM CORP5HOFFMANN LA ROCHE4
Top patents by PatentIndex Score
51 records- 0189US10035804B2Spirodiamine derivatives as aldosterone synthase inhibitorsHOFFMANN LA ROCHE·Filed 2017·Granted Jul 31, 2018·10 cites·20 claims
- 0287US12320944B1Method for calibrating prestack seismic inversion using fully connected neural networksCHINA PETROLEUM & CHEM CORP·Filed 2023·Granted Jun 3, 2025·2 cites·11 claims
- 0384US11733104B1High stability bluetooth temperature measuring probeSHENZHEN KUKI ELECTRONIC CO LTD·Filed 2023·Granted Aug 22, 2023·2 cites·13 claims
- 0481US10677949B2Anisotropy matching filtering for attenuation of seismic migration artifactsCHINA PETROLEUM & CHEM CORP·Filed 2018·Granted Jun 9, 2020·2 cites·3 claims
- 0580US10358494B2CS1-specific chimeric antigen receptor engineered immune effector cellsOHIO STATE INNOVATION FOUNDATION·Filed 2014·Granted Jul 23, 2019·5 cites·11 claims
- 0679US10227409B2CS1-specific chimeric antigen receptor engineered immune effector cellsOHIO STATE INNOVATION FOUNDATION·Filed 2017·Granted Mar 12, 2019·3 cites·9 claims
- 0777US11045543B2EGFR-directed car therapy for glioblastomaCYTOIMMUNE THERAPEUTICS INC·Filed 2016·Granted Jun 29, 2021·2 cites·33 claims
- 0877US10961312B2FLT3 directed car cells for immunotherapyCYTOIMMUNE THERAPEUTICS INC·Filed 2017·Granted Mar 30, 2021·1 cites·18 claims
- 0975US10973914B2Bivalent antibody directed against NKG2D and tumor associated antigensOHIO STATE INNOVATION FOUNDATION·Filed 2016·Granted Apr 13, 2021·2 cites·14 claims
- 1075US9603873B2Activation of innate immunity by miRNA for cancer and infection treatmentOHIO STATE INNOVATION FOUNDATION·Filed 2013·Granted Mar 28, 2017·3 cites·10 claims
- 1173US2025179194A1Compositions and methods for immunotherapy targeting flt3, pd-1, and/or pd-l1CYTOIMMUNE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1270US11459378B2Passive antibody dependent cell-mediated activationOHIO STATE INNOVATION FOUNDATION·Filed 2018·Granted Oct 4, 2022·1 cites·13 claims
- 1368US2025257138A1Immune cells expressing a hypoxia-dependent chimeric antigen receptor targeted to egfrHOPE CITY·Filed 2024·Application pending·0 cites
- 1467US10036516B2LED lampUNIV SHENZHEN·Filed 2016·Granted Jul 31, 2018·3 cites·7 claims
- 1567US2025090661A1Expansion of human group 2 innate lymphoid cells and methods of use thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 1667US2025360212A1Compositions and uses of psca targeted chimeric antigen receptor modified cells expressing il-15HOPE CITY·Filed 2024·Application pending·0 cites
- 1766US11845794B2CS1-specific chimeric antigen receptor engineered immune effector cellsOHIO STATE INNOVATION FOUNDATION·Filed 2019·Granted Dec 19, 2023·0 cites·17 claims
- 1866US2024047784A1Battery pack and vehicleHONDA MOTOR CO LTD·Filed 2023·Application pending·0 cites
- 1966US2024047781A1Battery pack and vehicleHONDA MOTOR CO LTD·Filed 2023·Application pending·0 cites
- 2065US12379516B2Systems and methods for reservoir characterizationCHINA PETROLEUM & CHEM CORP·Filed 2022·Granted Aug 5, 2025·0 cites·20 claims
- 2165US2024041875A1Methods of treating a coronavirus infectionHOPE CITY·Filed 2023·Application pending·0 cites
- 2264US2025017964A1Engineering or inducing pdgf and/or pdgfr signaling to enhance nk cell therapyHOPE CITY·Filed 2022·Application pending·0 cites
- 2362US2024016209A1Electronic cigaretteSHENZHEN KUKI ELECTRONIC CO LTD·Filed 2023·Application pending·0 cites
- 2460US2025186520A1Oncolytic virus compositions and methods for the treatment of cancerHOPE CITY·Filed 2021·Application pending·0 cites
- 2560US2025222102A1Nk cells expressing il-15 and checkpoint inhibitors for the treatment of cancerHOPE CITY·Filed 2022·Application pending·0 cites
- 2660US2024042897A1Battery pack and vehicleHONDA MOTOR CO LTD·Filed 2023·Application pending·0 cites
- 2759US2021308261A1Egfr-directed car therapy for glioblastomaCYTOIMMUNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2859US2015366914A1Methods for Mobilizing Hematopoietic Stem CellsOHIO STATE INNOVATION FOUNDATION·Filed 2014·Application pending·0 cites
- 2959US2021301024A1Compositions and methods for immunotherapy targeting flt3, pd-1, and/or pd-l1CYTOIMMUNE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3059US2021269534A1Flt3 directed car cells for immunotherapyCYTOIMMUNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3157US2024082398A1Methods of preparing and expanding type i innate lymphoid cells and therapeutic uses thereofHOPE CITY·Filed 2022·Application pending·0 cites
- 3257US2023405122A1Compositions and uses of psca targeted chimeric antigen receptor modified cellsHOPE CITY·Filed 2021·Application pending·0 cites
- 3357US2024299542A1Natural killer cells engineered to reduce or eliminate cbl-b and uses thereofHOPE CITY·Filed 2022·Application pending·0 cites
- 3456US2024141295A1Novel cell lines, methods of producing natural killer cells and uses thereofHOPE CITY·Filed 2021·Application pending·0 cites
- 3555US10253022B2Process for the preparation of N-[(3-aminooxetan-3-yl) methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amineHOFFMANN LA ROCHE·Filed 2018·Granted Apr 9, 2019·0 cites·3 claims
- 3655US2022281982A1Bispecific antibody car cell immunotherapyCYTOIMMUNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3755US2018207202A1Methods for mobilizing hematopoietic stem cellsOHIO STATE INNOVATION FOUNDATION·Filed 2018·Application pending·0 cites
- 3855US2023303654A1Compositions and uses of sars-cov-2 targeted chimeric antigen receptor modified nk cellsHOPE CITY·Filed 2021·Application pending·0 cites
- 3954US2023159644A1Flt3-targeted chimeric antigen receptor modified cells for treatment of flt3-positive malignanciesHOPE CITY·Filed 2021·Application pending·0 cites
- 4053US2023227549A1Oncolytic virus compositions and methods for the treatment of cancerHOPE CITY·Filed 2021·Application pending·0 cites
- 4152US12204060B2Full-wavefield angle gather for high-contrast inter thin-bed modelsCHINA PETROLEUM & CHEM CORP·Filed 2022·Granted Jan 21, 2025·0 cites·18 claims
- 4250US2022249564A1Pdl1 positive nk cell cancer treatmentHOPE CITY·Filed 2020·Application pending·0 cites
- 4349US11574197B2Method and apparatus for seismic imaging processing with enhanced geologic structure preservationCHINA PETROLEUM & CHEM CORP·Filed 2019·Granted Feb 7, 2023·0 cites·7 claims
- 4447US2021087275A1Bispecific antibody car cell immunotherapyCYTOIMMUNE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4547US2023242887A1Oncolytic virus carrying e-cadherin and uses thereofOHIO STATE INNOVATION FOUNDATION·Filed 2018·Application pending·0 cites
- 4645US10005770B2Process for the preparation of N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amineHOFFMANN LA ROCHE·Filed 2016·Granted Jun 26, 2018·0 cites·31 claims
- 4745US2025228895A1Compounds to inhibit ythdf2, t helper cells lacking expression of ythdf2, and methods to treat cancerHOPE CITY·Filed 2025·Application pending·0 cites
- 4839US11142534B2Process for the preparation of 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compoundsHOFFMANN LA ROCHE·Filed 2018·Granted Oct 12, 2021·0 cites·35 claims
- 4938US2005134181A1Pulsed high-power flash lamps made of compound quartz glass tubes and process for manufacture thereofFiled 2004·Application pending·0 cites
- 5035US2017119806A1Arylnaphthalene lactone derivatives and methods of making and using thereofOHIO STATE INNOVATION FOUNDATION·Filed 2015·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jianhua Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →